We are excited to welcome Dr. Sarah Goebel as a newly appointed research fellow supported by the IDDRC T32 training grant. Sarah brings with her a strong foundation in neuroscience, communication, and advocacy, and she is now shifting her focus to investigate autism spectrum disorders (ASD). As a T32 fellow, Sarah is investigating the hypothesis that deficits in oligodendrocyte function and disruptions in myelination are not secondary features but primary contributors to the diverse ASD. Her work seeks to uncover how altered glial function may drive the neurological and behavioral symptoms seen across the autism spectrum, with the potential to identify new therapeutic targets.

Sarah completed her Ph.D. in 2024 under the mentorship of Drs. Anna Francesconi and Vytautas “Vito” Verselis, focusing on Fragile X Syndrome. Her doctoral training sharpened her skills in analyzing complex scientific data and communicating research findings to a range of audiences. This ability to translate science across disciplines has been a consistent thread in her career.

Sarah also serves as scientific communication lead at the Salla Treatment and Research (STAR) Foundation, a nonprofit dedicated to rare disease research. She also co-founded Einstein for the Kids, an initiative that raises awareness and support for families affected by rare diseases. Sarah launched this program entirely on her own initiative—a true testament to her commitment to studying neurodevelopmental disorders and pursuing translational research that bridges basic science and patient impact.

With her deep commitment to both science and patient impact, Sarah is well-positioned to contribute meaningfully to the IDDRC and the broader field of autism research.